| Market Size in 2024 | Market Forecast in 2034 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 206.23 Million | USD 359.01 Million | 5.70% | 2024 |
FrequentlyAsked Questions
Paper-based plasma separation refers to innovative technologies that use specially designed paper materials to separate blood plasma from whole blood samples without centrifugation, enabling simpler, more accessible diagnostic testing in various healthcare settings.
The paper-based plasma separation market is expected to be driven by increasing demand for point-of-care diagnostics, advancements in paper material science, growing applications in resource-limited settings, integration with digital health platforms, and rising focus on accessible healthcare technologies.
According to our study, the global paper-based plasma separation market was worth around USD 206.23 million in 2024 and is predicted to grow to around USD 359.01 million by 2034.
The CAGR value of the paper-based plasma separation market is expected to be around 5.70% during 2025-2034.
The global paper-based plasma separation market will register the highest growth in North America during the forecast period, with Asia Pacific showing the fastest growth rate.
Key players in the paper-based plasma separation market include DiagnoTech Sciences, Global Health Innovations, MicroFlow Diagnostics, Abbott Laboratories, Roche Diagnostics, Siemens Healthineers, Danaher Corporation, Bio-Rad Laboratories, Becton Dickinson and Company, Thermo Fisher Scientific, Merck KGaA, PerkinElmer Inc., Qiagen N.V., BioMérieux SA, Abcam plc, Cytiva, Ahlstrom-Munksjö, Whatman, Pall Corporation, and Sartorius AG.
The report comprehensively analyzes the paper-based plasma separation market, including an in-depth discussion of market drivers, restraints, emerging trends, regional dynamics, and future growth opportunities. It also examines competitive dynamics, technological innovations, and the evolving healthcare needs shaping the paper-based plasma separation ecosystem.
HappyClients